CD8A and neoplasm: This process shares similarities with the proposed two-stage tumor-specific CD8+ T-cell activation previously reported (24), whereby initial activation in tumor-draining lymph nodes is followed by subsequent cytotoxic effector program acquisition after target recognition in the TME.